Redmile Group, LLC Atri Cure, Inc. Transaction History
Redmile Group, LLC
- $952 Million
- Q1 2025
Shares
3 transactions
Others Institutions Holding ATRC
# of Institutions
234Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$146 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$117 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$95.2 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$77.3 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.47B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...